help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fischer, A. H.
Right arrow Articles by Wynford-Thomas, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fischer, A. H.
Right arrow Articles by Wynford-Thomas, D.
(American Journal of Pathology. 1998;153:1443-1450.)
© 1998 American Society for Investigative Pathology


Regular Articles

Papillary Thyroid Carcinoma Oncogene (RET/PTC) Alters the Nuclear Envelope and Chromatin Structure

Andrew H. Fischer* , Jane A. Bond{dagger} , Panya Taysavang* , O. Eugene Battles* and David Wynford-Thomas{dagger}

From the Department of Pathology,* Emory University Hospital, Atlanta, Georgia, and the CRC Thyroid Tumour Biology Research Group,{dagger} Department of Pathology, University of Wales College of Medicine, Heath Park, Cardiff, United Kingdom

Current evidence suggests the papillary thyroid carcinoma oncogene (RET/PTC) generates papillary thyroid carcinomas in one genetic step. We tested a resulting prediction that RET/PTC expression in thyroid epithelium should be sufficient to cause the changes in nuclear morphology diagnostic of this tumor. Primary cultures of human thyroid epithelial cells were infected with a RET/PTC retroviral construct. Morphological scoring by two independent cytopathologists shows RET/PTC expression by immunohistochemistry to be highly associated (p << 0.0001) with an irregular nuclear contour and a euchromatic appearance compared with non-expressing cells in the same cultures. The altered nuclear morphology is not due to gene transfer or transformation per se as primary thyroid cell cultures infected with a retroviral H-RAS construct differ from RET/PTC-infected cells by showing round nuclear envelopes and coarser chromatin, as determined by the independent scoring of two cytopathologists (p << 0.0001). In addition, RET/PTC-transfected cells appear to disperse, whereas RAS-transfected cells grow as discrete colonies. The results provide additional support for the hypothesis that RET/PTC is sufficient to cause papillary thyroid carcinomas. A signaling pathway downstream of RET/PTC leads to restructuring of the nuclear envelope and chromatin, and the signal does not depend entirely, if at all, on a RAS pathway.





This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
M. Santoro, R. M. Melillo, and A. Fusco
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
Eur. J. Endocrinol., November 1, 2006; 155(5): 645 - 653.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. G. Borrello, L. Alberti, A. Fischer, D. Degl'Innocenti, C. Ferrario, M. Gariboldi, F. Marchesi, P. Allavena, A. Greco, P. Collini, et al.
Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene
PNAS, October 11, 2005; 102(41): 14825 - 14830.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. F. Louis, B. J. Vermolen, Y. Garini, I. T. Young, A. Guffei, Z. Lichtensztejn, F. Kuttler, T. C. Y. Chuang, S. Moshir, V. Mougey, et al.
c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus
PNAS, July 5, 2005; 102(27): 9613 - 9618.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D. A. Hill, S. Chiosea, S. Jamaluddin, K. Roy, A. H. Fischer, D. D. Boyd, J. A. Nickerson, and A. N. Imbalzano
Inducible changes in cell size and attachment area due to expression of a mutant SWI/SNF chromatin remodeling enzyme
J. Cell Sci., November 15, 2004; 117(24): 5847 - 5854.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. H. Fischer, P. Taysavang, and S. M. Jhiang
Nuclear Envelope Irregularity Is Induced by RET/PTC During Interphase
Am. J. Pathol., September 1, 2003; 163(3): 1091 - 1100.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Santoro, M. Papotti, G. Chiappetta, G. Garcia-Rostan, M. Volante, C. Johnson, R. L. Camp, F. Pentimalli, C. Monaco, A. Herrero, et al.
RET Activation and Clinicopathologic Features in Poorly Differentiated Thyroid Tumors
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 370 - 379.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
P. Smyth, O. Sheils, S. Finn, C. Martin, J. O'Leary, and E. C. Sweeney
Real-time Quantitative Analysis of E-cadherin Expression in ret/PTC-1-Activated Thyroid Neoplasms
International Journal of Surgical Pathology, October 1, 2001; 9(4): 265 - 272.
[Abstract] [PDF]


Home page
INT J SURG PATHOLHome page
J. Rosai
Editorial: Genes and Cancer
International Journal of Surgical Pathology, July 1, 2000; 8(3): 175 - 176.
[PDF]


Home page
INT J SURG PATHOLHome page
O. M. Sheils, J. J. O'Leary, V. Uhlmann, K. Luttich, and E. C. Sweeney
ret/PTC-1 Activation in Hashimoto Thyroiditis
International Journal of Surgical Pathology, July 1, 2000; 8(3): 185 - 189.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. C. Cheung, S. Ezzat, L. Ramyar, J. L. Freeman, and S. L. Asa
Molecular Basis of Hurthle Cell Papillary Thyroid Carcinoma
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 878 - 882.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Society for Investigative Pathology.